Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study

Autor: Jan G.P. Tijssen, Laura S.M. Kerkmeijer, Yoshinobu Onuma, Robbert J. de Winter, René J. van der Schaaf, Patrick W. Serruys, Joanna J. Wykrzykowska, Jan J. Piek, Ruben Y.G. Tijssen, Robin P. Kraak, Auke P.J.D. Weevers, Sjoerd H. Hofma, José P.S. Henriques, E. Karin Arkenbout

Publikováno v: Catheterization and Cardiovascular Interventions, 98(4), 713-720. Wiley-Liss Inc.
Catheterization and cardiovascular interventions, 98(4), 713-720. Wiley-Liss Inc.

Background: In this prespecified AIDA-trial sub-study we investigate the clinical performance of absorb bioresorbable vascular scaffold (BVS) compared to Xience everolimus-eluting stent (EES) in routine percutaneous coronary intervention (PCI) in pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685f120d924c93d084d63d6536ae236a
https://doi.org/10.1002/ccd.29329

A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial

Autor: Laura S.M. Kerkmeijer, Jan G.P. Tijssen, José P.S. Henriques, Karel T. Koch, Deborah N. Kalkman, Robbert J. de Winter, E. Karin Arkenbout, Sjoerd H. Hofma, Auke P.J.D. Weevers, Joanna J. Wykrzykowska, Marije M. Vis, René J. van der Schaaf, Marcel A.M. Beijk, Tineke H. Pinxterhuis, Jan Baan, Robin P. Kraak, Jan J. Piek, Ruben Y.G. Tijssen

Publikováno v: International journal of cardiology, 300, 93-98. Elsevier Ireland Ltd
International Journal of Cardiology, 300, 93-98. Elsevier Ireland Ltd

Background: Females are underrepresented in clinical trials evaluating new stent technologies whilst results may differ between the sexes. Females are known to have smaller, more tortuous coronary arteries and have generally more comorbidities. On th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759a993da3749b78bb9a7b93dfc8fee9
https://doi.org/10.1016/j.ijcard.2019.08.045

The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

Autor: Rodrigo Modolo, Robin P. Kraak, Martina Nassif, Deborah N. Kalkman, Sjoerd H. Hofma, Ply Chichareon, E. Karin Arkenbout, Jan J. Piek, José P.S. Henriques, Ruben Y.G. Tijssen, Jan G.P. Tijssen, Laura S.M. Kerkmeijer, Yoshinobu Onuma, Norihiro Kogame, Carlos Collet, Robbert J. de Winter, Yohei Sotomi, Yuki Katagiri, Marcel A.M. Beijk, Auke P.J.D. Weevers, Joanna J. Wykrzykowska, Taku Asano, Patrick W. Serruys, Kuniaki Takahashi, René J. van der Schaaf

Publikováno v: The International Journal of Cardiovascular Imaging
international journal of cardiovascular imaging, 35(7), 1189-1198. Springer Netherlands
International Journal of Cardiovascular Imaging, 35(7), 1189-1198. Springer Netherlands
Tijssen, R Y G, Kerkmeijer, L S M, Katagiri, Y, Kraak, R P, Takahashi, K, Kogame, N, Chichareon, P, Modolo, R, Asano, T, Nassif, M, Kalkman, D N, Sotomi, Y, Collet, C, Hofma, S H, van der Schaaf, R J, Arkenbout, E K, Weevers, A P J D, Beijk, M A M, Piek, J J, Tijssen, J G P, Henriques, J P, de Winter, R J, Onuma, Y, Serruys, P W & Wykrzykowska, J J 2019, ' The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial ', International Journal of Cardiovascular Imaging, vol. 35, no. 7, pp. 1189-1198 . https://doi.org/10.1007/s10554-019-01576-y

Due to expansion limits of the Absorb bioresorbable scaffold a meticulous implantation with correct sizing is required. We sought to investigate the clinical outcomes based on the sizing of the device related to the maximal lumen diameter measured by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf94b3172e61ac836079d85f2208fffc
https://doi.org/10.1007/s10554-019-01576-y

Four-Year Follow-Up of Absorb BVS Compared to Xience EES in Daily Clinical Practice Shows Continued Accrual of Events

Autor: José P.S. Henriques, Robbert J. de Winter, Joanna J. Wykrzykowska, Ruben Tijssen, Jan Tijssen, Jan J. Piek, Sjoerd H. Hofma, Hector M. Garcia-Garcia, E. Karin Arkenbout, Auke P.J.D. Weevers, René J. van der Schaaf, Laura S.M. Kerkmeijer, Eugene P. McFadden

Publikováno v: SSRN Electronic Journal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d218706be684df1e205a2373622269dc
https://doi.org/10.2139/ssrn.3684453

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Autor: Krzysztof Milewski, Michel Noutsias, Maciej Kośmider, Robbert J. de Winter, Yoshinobu Onuma, Yuki Katagiri, Sjoerd H. Hofma, Patrick W. Serruys, Paweł Buszman, Bas J B Hamer, E. Karin Arkenbout, William Wijns, Philipp Lurz, Jochen Wöhrle, Aleksander Żurakowski, Pascal Goube, Taku Asano, Dieter Fischer, Markus Ferrari, Karel T. Koch, Roland P.T. Troquay, Rafał Wyderka, Guillaume Cayla, Ton Oude Ophuis, Sébastien Levesque, Gillian A.J. Jessurun

Publikováno v: Lancet, 391(10119), 431-440. Elsevier Limited
Lancet
Lancet, Elsevier, 2018, 391 (10119), pp.431--440. ⟨10.1016/S0140-6736(17)33103-3⟩
Lancet (UK), 391(10119), 431-440. Elsevier Ltd.

International audience; BACKGROUND: MiStent is a drug-eluting stent with a fully absorbable polymer coating containing and embedding a microcrystalline form of sirolimus into the vessel wall. It was developed to overcome the limitation of current dur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c879f63e123c36a41e1fd19a71160dac
https://doi.org/10.1016/s0140-6736(17)33103-3